期刊文献+

泌尿系结石患者血清胱抑素C的含量变化分析 被引量:9

Study on variation of serum cystein C in patients with urinary stone
下载PDF
导出
摘要 目的探讨泌尿系结石患者血清胱抑素C(CysC)含量变化的临床应用价值。方法选择泌尿系结石患者44例为结石组,同期选择43例体检正常者为对照组。使用免疫比浊法测定血清CysC含量,并与血清尿素(Urea)、肌酐(Cr)含量比较,采用SPSS13.0软件进行统计学t检验。结果结石组中男、女性患者血清CysC含量分别为(1.24±0.22)和(1.13±0.27)mg/L,均明显高于对照组,差异有统计学意义(P<0.01),血清CysC与Urea和Cr含量之间呈正相关关系(r=0.445、0.571,P<0.01)。患者中合并肾积水7例,其血清CysC含量大幅度升高,与未伴肾积水组比较差异有统计学意义(P<0.01)。结论血清CysC可反映泌尿系结石患者肾功能的早期损伤。 Objective To study serum cystein C(CysC) concentration changes of urinary stone patients.Methods 44 patients with urinary stone were as the stone group and at the same period 43 cases of normal subjects were selected as the control group.The value of serum CysC was measured by immunoturbidimetric assay and compared with that of serum urea nitrogen(Urea),creatinine(Cr) content.SPSS13.0 software was used for t test.Results The values of serum cystein C(CysC) in males and females of urinary stone group were(1.24±0.22)mg/L and(1.13±0.27)mg/L,they were obviously higher than those in the healthy control group(P0.01).Serum CysC showed the positive correlations with urea and Cr levels(r=0.445,0.571,P0.01).Serum CysC levels of 7 hydronephrosis patients were increased obviously,showing significant difference compared with no hydronephrosis group(P0.01).Conclusion For the diagnosis of renal damage in early stage,the sensitivity of serum CysC is better.
出处 《检验医学与临床》 CAS 2011年第2期172-173,共2页 Laboratory Medicine and Clinic
关键词 尿路结石 半胱氨酸蛋白酶抑制剂 尿素 肌酸酐 肾/病理学 Urinary calculi cystein proteinase inhibitors Urea Creatinine kidney/pathology
  • 相关文献

参考文献8

二级参考文献56

  • 1段建敏,陈一戎,刘晓,伍莲生,刘国栋,李智.泌尿系结石患者肾功能损害[J].兰州医学院学报,1994,20(1):27-27. 被引量:2
  • 2李海霞,吴红花,徐国宾,郭晓蕙,夏铁安.血清半胱氨酸蛋白酶抑制剂C与肌酐在评价糖尿病患者肾小球滤过功能中的比较研究[J].中华检验医学杂志,2005,28(6):602-605. 被引量:107
  • 3徐国宾,朱立华,洪健美,刘静霞,夏铁安,周惠平,李庆红.尿中N-乙酰β-D氨基葡萄糖苷酶和β-半乳糖苷酶活力的测定[J].临床检验杂志,1995,13(1):20-21. 被引量:19
  • 4陆菊明.β2微球蛋白的临床意义[J].国外医学:内科学分册,1984,11(10):475-475.
  • 5陈一戎 刘国栋 沈绍基.尿NAG在泌尿外科疾病中的观察[J].中华泌尿外科杂志,1984,5(5):276-277.
  • 6Makise J.Kinetic rate assay of urinary N-acetyl-β-D-glucoaminidase with use of a new chromogenic substrate.Clin Chem,1988,34:2140-2145.
  • 7Orlando R,Mussap M,Plebani M.Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis.Clin Chem,2002,48(6Pt1):850 -858.
  • 8Stabuc B,Vrhovec L,Stabuc-Silih M,et al.Improved prediction of decreased creatinine clearance by serum cystatin C:use in cancer patients before and during chemotherapy.Clin Chem,2000,46 (2):193-197.
  • 9Curhan G.Cystatin C.A marker of renal function or something more?Clin Chem,2005,51 (2):293 -294.
  • 10Shlipak MG,Pranght ML,Sarnak MJ.Update on cystatin C:new insight into the importance of mildkidney dysfunction.Curr Opin Nephrol Hypertens,2006,15:270-275.

共引文献100

同被引文献102

引证文献9

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部